Sunday, June 26, 2022

Bionano Genomics Inc. (BNGO) may enjoy gains as insiders got busy in the recent days

In a filing, Bionano Genomics Inc. revealed its Director BARKER DAVID L acquired Company’s shares for reported $16000.0 on May 16. In the deal valued at $1.60 per share,10,000 shares were bought. As a result of this transaction, BARKER DAVID L now holds 13,894 shares worth roughly $ 20563.12.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Then, Holmlin R. Erik bought 5,025 shares, generating $20,037 in total proceeds. Upon buying the shares at $3.99, the President and CEO now owns 5,025 shares.

In the meantime, BTIG Research initiated its Bionano Genomics Inc. [BNGO] rating to a Buy in a research note published on Tuesday, June 16, 2021; the price target was $10. PT values the company’s stock at a premium of 85.2 to its Tuesday closing price. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Oppenheimer began covering BNGO with a “an Outperform” recommendation on April 08, 2020.

Price Performance Review of BNGO

On Tuesday, Bionano Genomics Inc. [NASDAQ:BNGO] saw its stock jump 3.50% to $1.48. On the same session, the stock had its day’s lowest price of $1.46, but rose to a high of $1.56. Over the last five days, the stock has gained 8.03%. Bionano Genomics Inc. shares have fallen nearly -50.50% since the year began. Nevertheless, the stocks have fallen -79.50% over the past one year. While a 52-week high of $8.20 was reached on 01/03/22, a 52-week low of $1.16 was recorded on 05/12/22. SMA at 50 days reached $1.6649, while 200 days put it at $3.1230. A total of 5.68 million shares were traded, compared to the trading of 4.43 million shares in the previous session.

Levels Of Support And Resistance For BNGO Stock

The 24-hour chart illustrates a support level at 1.4400, which if violated will result in even more drops to 1.4000. On the upside, there is a resistance level at 1.5400. A further resistance level may holdings at 1.6000. The Relative Strength Index (RSI) on the 14-day chart is 45.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1167, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 64.44%. Stochastics %K at 28.15% indicates the stock is a holding.

Bionano Genomics Inc. [BNGO] – Who Are The Largest Shareholders?

In filings from BlackRock Fund Advisors, it is revealed that the company now owns 16,416,245 shares, or roughly 5.67% of the outstanding BNGO shares. In other words, the investor’s shares have fallen by -192,762 from its previous 13-F filing of 16609007.0. Additionally, The Vanguard Group, Inc. increased 7.77% of its stake after which the total value it holdings stand at $26,223,551, while SSgA Funds Management, Inc. added 7.30% of its stake to hold $13.36 million in the firm. Over the last quarter, Geode Capital Management LLC sold -322,149 shares of Bionano Genomics Inc., while Northern Trust Investments, Inc. sold -73,822 shares. At present, Charles Schwab Investment Managem is holding 2,108,117 shares valued at $3.65 million. Morgan Stanley & Co. LLC owned 1,990,243 shares of the company at the time of its most recent 13F filing, worth $3.44 million.

According to FactSet, Bionano Genomics Inc.’s share price will average $8.67 in the next year, based on opinions of analysts polled by the firm. This is up nearly 459.44 percent from its previous closing price of $1.43. Analysts expect Bionano Genomics Inc. stock to reach the higher price of $12.00, while the lowest price estimate is $6.00. However, 3 analysts have rated BNGO stock as a Buy in their predictions for 2022.

Latest news

Related news


Please enter your comment!
Please enter your name here




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam